Navigation Links
Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
Date:9/14/2007

clinical study MDT3-005, "A Comparison of the Analgesic Efficacy of Tramadol Contramid OAD Versus Placebo in Patients with Pain Due to Osteoarthritis" has been published in the September 2007 edition of the Journal of Pain and Symptom Management (Vol. 34, # 3, Pages 328-338).

The article discusses the results of clinical trial MDT3-005, a multi-center, randomized, double-blind, parallel study designed to assess the analgesic efficacy and safety of Labopharm's once-daily formulation of tramadol compared to placebo in patients with osteoarthritis of the knee. An absolute mean reduction of 3.0 +/- 2.1 on an 11-point Pain Intensity Numerical Rating Scale (PI-NRS) was noted in the Labopharm once-daily tramadol treatment group. The difference between active and placebo groups was statistically significant (P less than 0.001). The responder analysis demonstrated that a significantly greater percentage of patients in the active treatment arm achieved clinical pain relief (a reduction greater than or equal to 2 points on the PI-NRS score) by the end of the study (P equals 0.035). A significantly greater percentage of respondents in the Labopharm once-daily tramadol group indicated improvement on both the Patient and Physician Global Impressions of Change (P equals 0.0002). Both the 200 mg and 300 mg doses contributed to the overall superiority of Labopharm's once-daily tramadol. The most frequent adverse events were consistent with the known side effects of tramadol and were generally mild to moderate in intensity. The article concludes that the results of the study confirm that Labopharm's once-daily tramadol given once daily is an efficacious and safe treatment for pain due to osteoarthritis.

An online version of the article is available for download at http://www.sciencedirect.com (fee of US$30).

Labopharm Secures Partner for Once-Daily Tramadol in Israel

Labopharm also announced that it has
'/>"/>

SOURCE Labopharm Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... IQ Formulations , a top national ... Inc. 500 , distinguishing it as one of the ... not only made the list, but was ranked in the ... past three years. It also ranked ninth among all health ... the second fastest growing company in the Miami metro area. ...
(Date:8/20/2014)... August 20, 2014 It’s no secret ... According to the National Institute on Drug Abuse, nearly ... drugs. What’s even more alarming is the fact that ... last decade. , Those locked in a struggle with ... way out. But now, the newly-redesigned AbuseTreatmentCenters.net has released ...
(Date:8/20/2014)... New York, NY (PRWEB) August 20, 2014 ... the world’s largest nutrition school, is proud to ... of Integral Studies (CIIS), a cutting-edge university ... Integrative Nutrition’s Health Coach Training Program are now ... Master of Arts in Integrative Health Studies. , ...
(Date:8/20/2014)... federal judge has remanded a lawsuit filed by a group ... to the City of St. Louis Circuit Court, reports the ... an assertion by the defendants that the plaintiffs’ claims should ... Fresenius Medical Care North America Inc., et al., No. 4:14-967) ... the dialysis products GranuFlo and NaturaLyte. In 2012, the U.S. ...
(Date:8/20/2014)... Clearwater, FL (PRWEB) August 20, 2014 ... their first-ever stem cell facial. Utilizing the new ... anti-aging treatment effectively targets fine lines and wrinkles ... recently announced August specials, highlighting the new service ... the purchase of the stem cell facial. , ...
Breaking Medicine News(10 mins):Health News:Leading Health Supplement Company IQ Formulations Among Inc. Magazine’s Top 50 Fastest Growing Private Companies in the United States 2Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 3Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3
... Helping Infertile Men and Women Find the Solutions to their Infertility ... Through Technology. , ... (PRWEB) May 16, 2009 -- ... couples that are struggling to be pregnant. National Fertility Link helps ...
... developments, The Villa Group encourages travelers to take advantage ... CDC today removed the Travel Health Warning against ... health safety. SAN DIEGO, May 15 In their ... in Mexico, CDC has noted that the virus activity ...
... cancer registriesone featuring transplant patients and the other the ... found that transplant patients experience worse outcomes from cancer. ... May 15, 2009, edition of the journal Transplantation ... MD, PhD, Jason Everly, PharmD, Steve Woodle, MD, and ...
... in Healthcare Technology Initiatives, Selected as Advisor to ... May 15 Cleveland Clinic Chief Information Officer ... to the U.S. Department of Health and Human ... of 23 experts appointed to the federal advisory ...
... Mass., May 15 Boston Scientific Corporation (NYSE: ... PCR Post-Op Summit in London.Jim Tobin, President and Chief Executive ... on Friday, May 22, beginning at approximately 9:30 a.m. London ... be available to all interested parties at Boston Scientific,s website ...
... 15 Herbal dietary supplement sales in the United ... figure of $4,800,000,000. A recent report published in the ... , based on data from multiple market research firms, ... 1% over 2007 sales.The HerbalGram report features ...
Cached Medicine News:Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 2Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 3Health News:Centers for Disease Control Lifts Travel Health Warning for Mexico 2Health News:Transplant patients have worse cancer outcomes, analysis shows 2Health News:Cleveland Clinic CIO Named to Federal Advisory Committee on Health Information Technology 2Health News:Herbal Supplement Sales Increase in US in 2008 2Health News:Herbal Supplement Sales Increase in US in 2008 3Health News:Herbal Supplement Sales Increase in US in 2008 4
(Date:8/19/2014)... Aug. 19, 2014   Lincor Inc. ... experience technology to New Jersey ... agreement, CarePoint Health will deploy Lincor,s PatientLINC technology ... Christ Hospital and Hoboken University Medical Center. ... of software solutions to help hospitals reach new ...
(Date:8/19/2014)... 19, 2014 Minimally Invasive Devices Inc. (MID), ... company, announced today that Mitsubishi Corporation has formally agreed ... system in Japan . MID anticipates ... Japan in the second half of ... distributor for Karl Storz GMBH & Co. (endoscopic instruments ...
(Date:8/19/2014)... , Aug. 19, 2014  Tokyo-based Atonarp Inc. ... funding round led by Walden Riverwood Ventures with ... development of Atonarp,s Smart Spectrometer technology platform, which ... company has targeted the oil & gas and ... "We are excited to partner with Atonarp in ...
Breaking Medicine Technology:Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2
... LLC (Berg) and GNS Healthcare, Inc. (GNS), a subsidiary ... into a joint venture named MAP Biosystems, LLC (MAP) ... critical biomedical research.  MAP will utilize a combination of ... and GNS,s patented supercomputer-driven REFS™ modeling and ...
... March 2, 2011 Accumetrics, Inc., a privately-held developer ... and easy-to-use point-of-care diagnostic system for measuring platelet reactivity ... has signed an agreement with Portola Pharmaceuticals, Inc. to ... use in clinical trials. The VerifyNow System ...
Cached Medicine Technology:Berg Biosystems and GNS Healthcare Announce Joint Venture - MAP Biosystems 2Berg Biosystems and GNS Healthcare Announce Joint Venture - MAP Biosystems 3Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc. 2
Force 1C has a streamlined, compact design perfect for the requirements of outpatient surgery - as well as the power and performance features needed for a full range of general inpatient surgical pro...
Diamond phaco knife keratome shaped blade straight. 3.2 mm wide....
... Excaliburplus PC, 100V, 50Hz/60Hz is the most ... V PTP in spray Coag. It is the ... power settings from the surgical field with a ... Output Voltage in CUT maintains minimum necessary voltage ...
The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Medicine Products: